Canopy Growth Corporation

28.39-0.6100-2.10%Vol 4.96M1Y Perf 52.18%
Nov 30th, 2020 11:17 DELAYED
BID28.39 ASK28.40
Open28.97 Previous Close29.00
Pre-Market- After-Market-
 - -%  - -
Target Price
22.14 
Analyst Rating
Hold 2.75
Potential %
-21.52 
Finscreener Ranking
★★★     49.77
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     52.32
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     59.33
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap10.56B 
Earnings Rating
Buy
Price Range Ratio 52W %
95.10 
Earnings Date
9th Nov 2020

Today's Price Range

27.6529.39

52W Range

9.0029.39

5 Year PE Ratio Range

-109.70-23.60

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
22.26%
1 Month
58.12%
3 Months
71.60%
6 Months
33.52%
1 Year
52.18%
3 Years
96.91%
5 Years
1 312.91%
10 Years
-

TickerPriceChg.Chg.%
CGC28.39-0.6100-2.10
AAPL117.971.38001.18
GOOG1 762.78-30.4100-1.70
MSFT211.62-3.6100-1.68
XOM38.86-1.3300-3.31
WFC27.82-0.6400-2.25
JNJ143.45-0.5500-0.38
FB273.29-4.5200-1.63
GE10.26-0.1400-1.35
JPM118.97-2.2500-1.86
Financial StrengthValueIndustryS&P 500US Markets
5.60
7.10
0.11
0.14
-253.80
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
4.30
-373.40
-343.00
-161.90
32.17
RevenueValueIndustryS&P 500US Markets
238.14M
0.92
86.60
122.36
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.230.16169.57
Q01 2021-0.28-0.2028.57
Q04 2020-0.30-1.16-286.67
Q03 2020-0.36-0.2725.00
Q02 2020-0.27-0.82-203.70
Q01 2020-0.29-0.2320.69
Q04 2019-0.17-0.67-294.12
Q03 2019-0.15-0.67-346.67
Earnings Per EndEstimateRevision %Trend
12/2020 QR-0.21-16.67Negative
3/2021 QR-0.180.00-
3/2021 FY-0.5061.24Positive
3/2022 FY-0.58-1.75Negative
Next Report Date-
Estimated EPS Next Report-0.23
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume4.96M
Shares Outstanding372.05M
Trades Count32.35K
Dollar Volume138.20M
Avg. Volume6.53M
Avg. Weekly Volume6.74M
Avg. Monthly Volume9.85M
Avg. Quarterly Volume6.53M

Canopy Growth Corporation (NYSE: CGC) stock closed at 29 per share at the end of the most recent trading day (a 7.93% change compared to the prior day closing price) with a volume of 7.60M shares and market capitalization of 10.56B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 4550 people. Canopy Growth Corporation CEO is Mark Zekulin.

The one-year performance of Canopy Growth Corporation stock is 52.18%, while year-to-date (YTD) performance is 37.51%. CGC stock has a five-year performance of 1312.91%. Its 52-week range is between 9 and 29.39, which gives CGC stock a 52-week price range ratio of 95.10%

Canopy Growth Corporation currently has a PE ratio of 52.60, a price-to-book (PB) ratio of 2.35, a price-to-sale (PS) ratio of 19.30, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -19.85%, a ROC of -27.09% and a ROE of -28.68%. The company’s profit margin is 32.17%, its EBITDA margin is -343.00%, and its revenue ttm is $238.14 Million , which makes it $0.92 revenue per share.

Of the last four earnings reports from Canopy Growth Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.23 for the next earnings report. Canopy Growth Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Canopy Growth Corporation is Hold (2.75), with a target price of $22.14, which is -21.52% compared to the current price. The earnings rating for Canopy Growth Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Canopy Growth Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Canopy Growth Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 41.28, ATR14 : 1.71, CCI20 : 154.00, Chaikin Money Flow : 0.00, MACD : 1.77, Money Flow Index : 74.68, ROC : 29.96, RSI : 70.51, STOCH (14,3) : 69.46, STOCH RSI : 0.88, UO : 53.65, Williams %R : -30.54), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Canopy Growth Corporation in the last 12-months were: Phillip Shaer (Option Excercise at a value of $370 932), Phillip Shaer (Sold 70 000 shares of value $2 172 100 ), Rade Kovacevic (Option Excercise at a value of $755 993), Rade Kovacevic (Sold 241 038 shares of value $7 604 360 ), Tomas Shipley (Option Excercise at a value of $599 864), Tomas Shipley (Sold 73 333 shares of value $1 693 992 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (25.00 %)
6 (40.00 %)
7 (43.75 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
10 (62.50 %)
9 (60.00 %)
8 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
1 (6.25 %)
Strong Sell
2 (12.50 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.75
Moderate Buy
2.20
Moderate Buy
2.19

Canopy Growth Corporation

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

CEO: Mark Zekulin

Teplephone: +1 855 558-9333

Address: 1 Hershey Drive, Smiths Falls K7A 0A8, ON, CAN

Number of employees: 4 550

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

54%46%

Bearish Bullish

53%47%

Bearish Bullish

49%51%

News

Stocktwits